Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Multiparametric immune profiling in HPV– oral squamous cell cancer
Zipei Feng, … , Barbara Seliger, Bernard A. Fox
Zipei Feng, … , Barbara Seliger, Bernard A. Fox
Published July 20, 2017
Citation Information: JCI Insight. 2017;2(14):e93652. https://doi.org/10.1172/jci.insight.93652.
View: Text | PDF
Research Article Immunology Oncology

Multiparametric immune profiling in HPV– oral squamous cell cancer

  • Text
  • PDF
Abstract

Evaluation of T lymphocyte frequency provides prognostic information for patients with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T cell frequency and assessing suppressive elements and defects in antigen-processing machinery (APM) has not been clarified. Simultaneous characterization of CD3+, CD8+, FoxP3+, CD163+, and PD-L1+ cells using multispectral imaging was performed on sections from 119 patients with HPV– OSCC. Expression of β2-microglobulin, MHC class I heavy chain, and large multifunctional peptidase 10 was quantified, and all data were correlated with patient outcome. We found that, consistent with previous reports, high numbers of CD8+ T cells at the invasive margin correlated significantly with prolonged overall survival (OS), while the number of FoxP3+ or PD-L1+ cells did not. Compiling the number of FoxP3+ or PD-L1+ cells within 30 μm of CD8+ T cells identified a significant association with a high number of suppressive elements close to CD8+ T cells and reduced OS. Integrating this information into a cumulative suppression index (CSI) increased correlation with OS. Incorporating tumor expression levels of APM components with CSI further improved prognostic power. This multiparametric immune profiling may be useful for stratifying patients with OSCC for clinical trials.

Authors

Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, Alexander Eckert, R. Bryan Bell, Allen Cheng, Tuan Bui, Rom Leidner, Walter J. Urba, Kent Johnson, Clifford Hoyt, Carlo B. Bifulco, Juergen Bukur, Claudia Wickenhauser, Barbara Seliger, Bernard A. Fox

×

Figure 1

Differences in density and location of immune infiltrate in OSCC, as a typical example of squamous cell carcinoma, compared with colorectal cancer, as a typical example of intestinal adenocarcinoma.

Options: View larger image (or click on image) Download as PowerPoint
Differences in density and location of immune infiltrate in OSCC, as a t...
(A) Representative example with demonstration of topographic position of CD8+ infiltrate in OSCC (original magnification, ×40). (B) Representative example of CD8+ infiltrate in colorectal cancer (CRC) (original magnification, ×40). (C) Enumeration of immune cell infiltrate using the Definiens platform. In OSCC, most CD8+ cells are located within the stromal side invasive margin (IM), while, in CRC, the majority of CD8+ cells are located within the tumor and tumor side IM. Data are represented as dot plots (mean ± SEM). Two-tailed unpaired t test was performed to test statistical significance. n = 55 for OSCC, n = 199 for CRC. CT, core of tumor.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts